Abstract
Purpose of Review: This review aims to consolidate recent observations regarding extra-osseous roles of the RANK-RANKL-OPG axis, primarily within skeletal muscle. Recent Findings: Preclinical efforts to decipher a common signalling pathway that links the synchronous decline in bone and muscle health in ageing and disease disclosed a potential role of the RANK-RANKL-OPG axis in skeletal muscle. Evidence suggests RANKL inhibition benefits skeletal muscle function, mass, fibre-type switching, calcium homeostasis and reduces fall incidence. However, there still exists ambiguity regarding the exact mechanistic actions and subsequent functional improvements. Other potential RANK-RANKL-OPG extra-osseous roles include regulation of neural-inflammation and glucose metabolism. Summary: Growing evidence suggests the RANK-RANKL-OPG axis may play a regulatory role in extra-osseous tissues, especially in skeletal muscle. Targeting RANKL may be a novel therapy in ameliorating loss of muscle mass and function. More research is warranted to determine the causality of the RANK-RANKL-OPG axis in extra-osseous tissues, especially those affected by aging.
| Original language | English |
|---|---|
| Pages (from-to) | 632-650 |
| Number of pages | 19 |
| Journal | Current Osteoporosis Reports |
| Volume | 22 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - Dec 2024 |
Keywords
- Denosumab
- Extra-osseous
- NF-κB signalling
- Osteoprotegerin
- RANK-RANKL-OPG axis
- Skeletal muscle
Fingerprint
Dive into the research topics of 'Extra-osseous Roles of the RANK-RANKL-OPG Axis with a Focus on Skeletal Muscle'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver